New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
13:46 EDTPBYIPuma Biotechnology June volatility elevated at 127 into ASCO
Puma Biotechnology June call option implied volatility is at 127, July is at 112, September is at 102, December is at 91; compared to its 26-week average of 88 according to Track Data, suggesting large near term price movement into ASCO's 50th annual meeting taking place May 30 through June 3.
News For PBYI From The Last 14 Days
Check below for free stories on PBYI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2014
07:12 EDTPBYIPuma Biotechnology neratinib use unlikely to be limited, says Citigroup
Although Puma's Neratinib breast cancer drug was enriched for high risk HER2+ patients during a recent trial, Citigroup does not expect its use to be restricted to high risk women. The firm keeps a $292 price target and Buy rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use